Utilizing chromatin directed inhibitors to regulate gene expression in Ewing sarcoma for therapeutic benefit |
University of North Carolina / Justin Sperlazza, MD/PhD |
Young Investigator Grants |
2024 |
North Carolina |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond |
Albert Einstein College of Medicine / Kristy Stengel |
RUNX1 Early Career Investigator Grants |
2022 |
New York |
Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents
|
Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD |
Phase I/II Infrastructure Grants |
2006 |
Washington |
Untangling the Matrix in Medulloblastoma
|
St. Christopher's Hospital for Children / Duncan Stearns, MD |
Young Investigator Grants |
2008 |
Ohio |
Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma |
Case Western Reserve University / Berkley Gryder, PhD |
'A' Award Grants |
2023 |
Ohio |
Unraveling metabolic dependencies in childhood supratentorial ependymomas. |
Regents of the University of Michigan / Sriram Venneti, MD/PhD |
Innovation Grants |
2021 |
Michigan |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |